BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12894541)

  • 1. Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer.
    Yamaue H; Tanimura H; Kono N; Aoki Y; Tabuse K; Uchiyama K; Takifuji K; Iwahashi M; Tani M
    Anticancer Res; 2003; 23(3B):2559-64. PubMed ID: 12894541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
    Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase expression and efficacy of adjuvant doxifluridine in advanced colorectal cancer patients.
    Hasegawa S; Seike K; Koda K; Takiguchi N; Oda K; Hasegawa R; Miyazaki M
    Oncol Rep; 2005 Apr; 13(4):621-6. PubMed ID: 15756433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
    Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
    Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
    Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.
    Koda K; Miyazaki M; Sarashina H; Suwa T; Saito N; Suzuki M; Ogawa K; Watanabe S; Kodaira S; Nakazato H
    Int J Oncol; 2003 Jul; 23(1):165-72. PubMed ID: 12792790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thymidine phosphorylase expressed in monocyte-macrophages enhanced anticancer effect of 5'-deoxy-5-fluorouridine on colorectal carcinoma cells].
    Zhang JM; Liu MJ; Mizoi T; Shiiba K; Sasak I; Matsuno S
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):718-24. PubMed ID: 15200906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
    Ishii R; Takiguchi N; Oda K; Koda K; Miyazaki M
    Int J Oncol; 2001 Oct; 19(4):717-22. PubMed ID: 11562746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
    Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y
    Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of 5'-deoxy-5-fluorouridine sensitivity in colorectal cancer cases by thymidine phosphorylase activity and preliminary identification of susceptibility related genes.
    Mimori K; Ueo H; Kuroki T; Shiraishi T; Creer S; Taylor S; Ishii H; Mori M
    Oncol Rep; 2004 Jul; 12(1):19-23. PubMed ID: 15201953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine phosphorylase expression and effect of doxifluridine: a phase II study.
    Sadahiro S; Otani Y; Oya K; Ike H; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T
    Oncol Rep; 2001; 8(4):753-8. PubMed ID: 11410777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of patients with superficial bladder cancer by intravesical instillation of anticancer drugs plus oral chemotherapy following TUR-Bt: a randomized controlled trial.
    Matsushima H; Kawabe K; Fujime M; Kitamura T; Homma Y; Kishi H; Kawamura T; Umeda T; Ohishi Y; Murai M; Kawai T; Yoshida H; Fukuda T
    Oncol Rep; 2002; 9(2):283-8. PubMed ID: 11836593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine phosphorylase expressed in macrophages enhances antitumor effect of 5'-deoxy-5-fluorouridine on human colorectal carcinoma cells.
    Zhang J; Mizoi T; Harada N; Shiiba K; Miyagawa K; Matsuno S; Sasaki I
    Anticancer Res; 2003; 23(1A):323-9. PubMed ID: 12680231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine phosphorylase and dihydropyrimidine dehydrogenase activity in colorectal carcinoma and patients prognosis.
    Ikeguchi M; Makino M; Kaibara N
    Langenbecks Arch Surg; 2002 Oct; 387(5-6):240-5. PubMed ID: 12410361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrimidine nucleoside phosphorylase and dihydropyrimidine dihydrogenase activities as predictive factors for the efficacy of doxifluridine together with mitomycin C as adjuvant chemotherapy in primary colorectal cancer.
    Nishioka M; Miyamoto H; Kurita N; Higashijima J; Yoshikawa K; Miyatani T; Shimada M
    Hepatogastroenterology; 2007 Jun; 54(76):1089-93. PubMed ID: 17629045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes.
    Yasuno H; Kurasawa M; Yanagisawa M; Sato Y; Harada N; Mori K
    Oncol Rep; 2013 Feb; 29(2):451-8. PubMed ID: 23229803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon-alpha in renal cell carcinoma cell lines.
    Ikemoto S; Sugimura K; Yoshida N; Kuratsukuri K; Wada S; Nakatani T
    Urol Int; 2004; 73(4):348-53. PubMed ID: 15604581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients.
    Tominaga T; Toi M; Ohashi Y; Abe O;
    Clin Breast Cancer; 2002 Apr; 3(1):55-64. PubMed ID: 12020396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfection of thymidine phosphorylase cDNA with lentiviral vector enhances the anticancer effect of 5'-deoxy-5-fluorouridine on colorectal cancer cell lines HT29 and LS174T].
    Ye D; Wang Q; Zhang J; Liu Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):18-24. PubMed ID: 25877313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.